Dolby Laboratories, Inc. (NYSE:DLB) Q2 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories conference call discussing second quarter fiscal year 2026 results.
Dolby Laboratories Inc. (DLB)
Market is closed
Sector: Patent Owners & Lessors
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 582,031 | $30,603,190 | +1544% | 0% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 527,158 | $27,717,968 | +324% | 0.01% |
| 3. | Millennium Management Israel Englander | 420,067 | $22,087,123 | -3% | 0.01% |
| 4. | D E Shaw D. E. Shaw | 415,005 | $21,820,963 | +6% | 0.01% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 343,678 | $18,070,591 | +465% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $78.15 | 3 | $200.00 | 3 | 2024-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $62.71 | 3,000 | $188,130.00 | 73,274 | 2026-08-14 | Filing | |
| $62.04 | 1,348 | $83,629.92 | 35,636 | 2026-08-10 | Filing | |
| $60.63 | 357 | $21,644.91 | 36,984 | 2026-08-04 | Filing | |
| $60.11 | 6,884 | $413,780.03 | 118,727 | 2026-08-03 | Filing | |
| $59.03 | 783 | $46,223.86 | 125,611 | 2026-08-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,676,885 | $351,070,612 | 0.01% | |
| 2. | 4,950,702 | $260,307,911 | 0.01% | |
| 3. | 4,817,216 | $253,289,205 | 0.04% | |
| 4. | 4,601,750 | $241,960,122 | 0.01% | |
| 5. | 2,721,876 | $143,116,240 | 0% |
News See All
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories conference call discussing first quarter 2026 results.
Do You Believe in the Growth Potential of Dolby Laboratories (DLB)?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the Dolby Laboratories Conference Call discussing Fourth Quarter Fiscal Year 2025 Results.
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories conference call discussing third quarter fiscal year 2025 results.
Does Dolby Laboratories (DLB) have an Enhanced Margin Potential?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Second Quarter Fiscal Year 2025 Results.
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing First Quarter Fiscal Year 2025 results.
14 Best 52-Week High Stocks To Buy According to Analysts
After two years of substantial gains to record highs, exhaustion in the US equity markets is slowly kicking in.
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2024 Earnings Call Transcript
Operator: Hello, ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal Fourth Quarter Results.
Hedge Fund Resource Center